Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of Workplace Disability in a Premanifest Huntington's Disease Cohort.
Goh AMY, You E, Perin S, Clay FJ, Loi S, Ellis K, Chong T, Ames D, Lautenschlager N. Goh AMY, et al. Among authors: lautenschlager n. J Neuropsychiatry Clin Neurosci. 2018 Spring;30(2):115-121. doi: 10.1176/appi.neuropsych.17040086. Epub 2017 Nov 29. J Neuropsychiatry Clin Neurosci. 2018. PMID: 29183234
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D; AIBL Research Group. Ellis KA, et al. Among authors: lautenschlager nt. Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27. Int Psychogeriatr. 2009. PMID: 19470201
The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease.
Cyarto EV, Cox KL, Almeida OP, Flicker L, Ames D, Byrne G, Hill KD, Beer CD, LoGiudice D, Appadurai K, Irish M, Renehan E, Lautenschlager NT. Cyarto EV, et al. Trials. 2010 Dec 10;11:120. doi: 10.1186/1745-6215-11-120. Trials. 2010. PMID: 21143943 Free PMC article. Clinical Trial.
Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe C, Szoeke C, Ellis KA; AIBL research group. Sittironnarit G, et al. Among authors: lautenschlager nt. Dement Geriatr Cogn Disord. 2011;31(3):173-8. doi: 10.1159/000325171. Epub 2011 Mar 9. Dement Geriatr Cogn Disord. 2011. PMID: 21389718
Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA; AIBL Research Group. Sona A, et al. Among authors: lautenschlager nt. Int Psychogeriatr. 2012 Feb;24(2):197-204. doi: 10.1017/S1041610211001335. Epub 2011 Jul 13. Int Psychogeriatr. 2012. PMID: 21749739
Blood-based protein biomarkers for diagnosis of Alzheimer disease.
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarker and Lifestyle Research Group. Doecke JD, et al. Arch Neurol. 2012 Oct;69(10):1318-25. doi: 10.1001/archneurol.2012.1282. Arch Neurol. 2012. PMID: 22801742 Free PMC article.
Personality of mental health caregivers.
Lautenschlager NT, Kurz AF, Loi S, Cramer B. Lautenschlager NT, et al. Curr Opin Psychiatry. 2013 Jan;26(1):97-101. doi: 10.1097/YCO.0b013e32835997b3. Curr Opin Psychiatry. 2013. PMID: 23041793 Review.
Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial.
Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL. Cyarto EV, et al. Among authors: lautenschlager nt. BMC Psychiatry. 2012 Oct 11;12:167. doi: 10.1186/1471-244X-12-167. BMC Psychiatry. 2012. PMID: 23050829 Free PMC article. Clinical Trial.
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group. Burnham SC, et al. Mol Psychiatry. 2014 Apr;19(4):519-26. doi: 10.1038/mp.2013.40. Epub 2013 Apr 30. Mol Psychiatry. 2014. PMID: 23628985
281 results